Dermira (DERM) Tops Q2 EPS by 12c

Dermira (NASDAQ: DERM) reported Q2 EPS of $0.10, $0.12 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $18.37 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
• NextPlat Corp (NXPL) Reports Q2 Loss of $0.05